Entyvio (Vedolizumab)
$4,622.50
300 mg CAJ FAM C/1
... people are viewing this right now
Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Millennium Pharmaceuticals, Inc for the treatment of ulcerative colitis and Crohn's disease.
Reviews
There are no reviews yet.